Armata Pharmaceuticals Inc (ARMP)
Fair Value-23.4% Downside
Overvalued
Analyst280.4% Upside
Market Cap172.9 M
P/E-0.6x
Yield0.0%
HealthWeak
NYSE
Featured in
Overvalued Stocks
Protalix Biotherapeutics Inc (PLX)
Analyst344.4% Upside
Market Cap198.2 M
P/E13.0x
Yield0.0%
HealthGreat
NYSE
Featured in
Overvalued Stocks
High-Beta Stocks
Arcus Biosciences Inc (RCUS)
Fair Value-5.9% Downside
Fair
Analyst34.0% Upside
Market Cap3.644 B
P/E-8.0x
Yield0.0%
HealthWeak
NYSE
Featured in
Overvalued Stocks